retatrutide type 2 diabetes phase 2 trial results 2024 Test on a popular unapproved peptide have revealed a concentration double that listed on the label, prompting warnings from health professionals about "enormous" overdose risks. By national health equity reporters Caitlyn Retatrutide Severe Obesity Trial Shows
Description
Our providers are trained to assess your risk and prescribe responsibly
Interestingly, recent research has shed light on how GLP-1 drugs can also play a role in suppressing addiction in patients suffering from alcohol or substance use disorders
All methods in the clinical study were performed in accordance with relevant guidelines and regulations
Scientists are running clinical trials to see if semaglutide can be used for alcohol use disorder
The authors suggest that early use of GLP-1 RAs is necessary and could also be focused on metabolic outcomes
